Rici Healthcare Holdings Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Yixin Fang
Chief executive officer
CN¥571.0k
Total compensation
| CEO salary percentage | 84.6% |
| CEO tenure | 5.8yrs |
| CEO ownership | n/a |
| Management average tenure | 5.8yrs |
| Board average tenure | 8.5yrs |
Recent management updates
Recent updates
Does Rici Healthcare Holdings (HKG:1526) Have A Healthy Balance Sheet?
Oct 17
Solid Earnings Reflect Rici Healthcare Holdings' (HKG:1526) Strength As A Business
May 01If EPS Growth Is Important To You, Rici Healthcare Holdings (HKG:1526) Presents An Opportunity
Dec 22Returns On Capital Are A Standout For Rici Healthcare Holdings (HKG:1526)
Dec 06Is Rici Healthcare Holdings (HKG:1526) A Risky Investment?
Apr 07Rici Healthcare Holdings' (HKG:1526) Returns On Capital Are Heading Higher
Feb 15Does Rici Healthcare Holdings (HKG:1526) Have A Healthy Balance Sheet?
Dec 15Here's Why Rici Healthcare Holdings (HKG:1526) Has A Meaningful Debt Burden
Sep 13Rici Healthcare Holdings' (HKG:1526) Strong Earnings Are Of Good Quality
May 09Rici Healthcare Holdings (HKG:1526) Has A Somewhat Strained Balance Sheet
Nov 02Rici Healthcare Holdings (HKG:1526) Will Be Hoping To Turn Its Returns On Capital Around
Aug 23These 4 Measures Indicate That Rici Healthcare Holdings (HKG:1526) Is Using Debt Extensively
May 08Rici Healthcare Holdings (HKG:1526) Might Be Having Difficulty Using Its Capital Effectively
Apr 12Is Rici Healthcare Holdings Limited (HKG:1526) Popular Amongst Insiders?
Mar 08Would Shareholders Who Purchased Rici Healthcare Holdings' (HKG:1526) Stock Three Years Be Happy With The Share price Today?
Jan 14Is Rici Healthcare Holdings Limited (HKG:1526) Popular Amongst Insiders?
Nov 23CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥325m |
| Mar 31 2024 | n/a | n/a | CN¥345m |
| Dec 31 2023 | CN¥571k | CN¥483k | CN¥364m |
| Jun 30 2023 | n/a | n/a | CN¥414m |
| Mar 31 2023 | n/a | n/a | CN¥340m |
| Dec 31 2022 | CN¥2m | CN¥282k | CN¥267m |
| Jun 30 2022 | n/a | n/a | CN¥315m |
| Mar 31 2022 | n/a | n/a | CN¥332m |
| Dec 31 2021 | CN¥3m | CN¥311k | CN¥349m |
| Sep 30 2021 | n/a | n/a | CN¥174m |
| Jun 30 2021 | n/a | n/a | CN¥167m |
| Mar 31 2021 | n/a | n/a | CN¥79m |
| Dec 31 2020 | CN¥3m | CN¥321k | -CN¥8m |
| Sep 30 2020 | n/a | n/a | -CN¥90m |
| Jun 30 2020 | n/a | n/a | -CN¥173m |
| Mar 31 2020 | n/a | n/a | -CN¥121m |
| Dec 31 2019 | CN¥4m | CN¥300k | -CN¥69m |
| Sep 30 2019 | n/a | n/a | -CN¥58m |
| Jun 30 2019 | n/a | n/a | -CN¥46m |
| Mar 31 2019 | n/a | n/a | -CN¥50m |
| Dec 31 2018 | CN¥4m | CN¥300k | -CN¥54m |
| Sep 30 2018 | n/a | n/a | -CN¥72m |
| Jun 30 2018 | n/a | n/a | -CN¥91m |
| Mar 31 2018 | n/a | n/a | -CN¥76m |
| Dec 31 2017 | CN¥4m | CN¥300k | -CN¥62m |
Compensation vs Market: Yixin's total compensation ($USD78.23K) is below average for companies of similar size in the Hong Kong market ($USD348.00K).
Compensation vs Earnings: Yixin's compensation has been consistent with company performance over the past year.
CEO
Yixin Fang (59 yo)
5.8yrs
Tenure
CN¥571,000
Compensation
Dr. Yixin Fang has been Chief Executive Officer of Rici Healthcare Holdings Ltd since March 20, 2019. Dr. Fang is the Founder of Rici Healthcare Holdings Limited. Dr. Fang serves as the Chairman of Rici He...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 5.8yrs | CN¥571.00k | no data | |
| COO, VP | no data | CN¥723.00k | no data | |
| VP & Executive Director | no data | CN¥1.26m | 60.28% HK$ 1.2b | |
| Executive VP | no data | CN¥586.00k | no data | |
| Chief Financial Officer | 7.6yrs | no data | no data | |
| Chief Legal Officer | no data | no data | no data | |
| Company Secretary | 4.9yrs | no data | no data |
5.8yrs
Average Tenure
45yo
Average Age
Experienced Management: 1526's management team is seasoned and experienced (5.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 8.8yrs | CN¥571.00k | no data | |
| COO, VP | 5.5yrs | CN¥723.00k | no data | |
| VP & Executive Director | 10.4yrs | CN¥1.26m | 60.28% HK$ 1.2b | |
| Executive VP | 5.5yrs | CN¥586.00k | no data | |
| Independent Non-Executive Director | 8.5yrs | CN¥180.00k | no data | |
| Independent Non-Executive Director | 7.5yrs | CN¥150.00k | no data | |
| Independent Non-Executive Director | 8.5yrs | CN¥180.00k | no data |
8.5yrs
Average Tenure
56yo
Average Age
Experienced Board: 1526's board of directors are considered experienced (8.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 02:42 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Rici Healthcare Holdings Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Iris Wang | Credit Suisse |